Phoenix Nest is a collaborative company focused on treating Sanfilippo Syndrome (Mucopolysaccharidosis (MPS) IIIB, IIIC and IIID). Our goal is to bring these treatments to market as quickly as possible. We are working with the leading academics and have engaged in a strategy of licensing key technologies to facilitate this goal.